The Effectiveness of E-Cigarettes for Smoking Cessation.
Journal
Deutsches Arzteblatt international
ISSN: 1866-0452
Titre abrégé: Dtsch Arztebl Int
Pays: Germany
ID NLM: 101475967
Informations de publication
Date de publication:
29 04 2022
29 04 2022
Historique:
received:
28
09
2021
revised:
28
09
2021
accepted:
03
03
2022
pubmed:
7
4
2022
medline:
3
8
2022
entrez:
6
4
2022
Statut:
ppublish
Résumé
Our primary aim was to assess-in the German population-the effectiveness of e-cigarettes (ECs; with or without nicotine), nicotine replacement therapy (NRT), and no use of evidence-based aids in smoking cessation. Analysis of cross-sectional data from a representative survey of the population (age 14-96 years) conducted in 2016-2021. All current smokers and recent ex-smokers (< 12 months since quitting) who had made ≥ 1 attempt to quit in the past 12 months (n = 2740) were included. They were asked about use of cessation aids in their most recent quit attempt and their current smoking status. Two hundred thirty-nine respondents had used ECs, 168 NRT, and 2333 no aid. After adjustment for potential confounders, the odds of abstinence were 1.78 times higher for smokers who had used ECs in their quit attempt than in the group that had used no aids (95% confidence interval [1.09; 2.92]; p = 0.02) and 1.46 times higher than in the NRT group ([0.68; 3.13]; p = 0.34, Bayes factor = 1.26). Compared with the unaided group, the odds of abstinence were 2.34 times higher ([1.21; 4.53]; p = 0.01) in the subgroup using ECs with nicotine and 1.48 times higher ([0.68; 3.26]; p = 0.33) in the subgroup using ECs without nicotine. The unadjusted abstinence rates in people who had started their quit attempt > 6 months earlier were 15.6% [9.4; 23.8] in the ECs group and 13.8% [7.3; 22.9] in the NRT group. In Germany, use of ECs in an attempt to quit smoking is associated with a higher rate of abstinence than attempting to quit unaided.
Sections du résumé
BACKGROUND
Our primary aim was to assess-in the German population-the effectiveness of e-cigarettes (ECs; with or without nicotine), nicotine replacement therapy (NRT), and no use of evidence-based aids in smoking cessation.
METHODS
Analysis of cross-sectional data from a representative survey of the population (age 14-96 years) conducted in 2016-2021. All current smokers and recent ex-smokers (< 12 months since quitting) who had made ≥ 1 attempt to quit in the past 12 months (n = 2740) were included. They were asked about use of cessation aids in their most recent quit attempt and their current smoking status.
RESULTS
Two hundred thirty-nine respondents had used ECs, 168 NRT, and 2333 no aid. After adjustment for potential confounders, the odds of abstinence were 1.78 times higher for smokers who had used ECs in their quit attempt than in the group that had used no aids (95% confidence interval [1.09; 2.92]; p = 0.02) and 1.46 times higher than in the NRT group ([0.68; 3.13]; p = 0.34, Bayes factor = 1.26). Compared with the unaided group, the odds of abstinence were 2.34 times higher ([1.21; 4.53]; p = 0.01) in the subgroup using ECs with nicotine and 1.48 times higher ([0.68; 3.26]; p = 0.33) in the subgroup using ECs without nicotine. The unadjusted abstinence rates in people who had started their quit attempt > 6 months earlier were 15.6% [9.4; 23.8] in the ECs group and 13.8% [7.3; 22.9] in the NRT group.
CONCLUSION
In Germany, use of ECs in an attempt to quit smoking is associated with a higher rate of abstinence than attempting to quit unaided.
Identifiants
pubmed: 35384835
pii: arztebl.m2022.0162
doi: 10.3238/arztebl.m2022.0162
pmc: PMC9450504
doi:
pii:
Substances chimiques
Nicotine
6M3C89ZY6R
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
297-301Références
Lancet. 2013 Nov 16;382(9905):1629-37
pubmed: 24029165
Dtsch Arztebl Int. 2018 Apr 6;115(14):235-242
pubmed: 29716687
BMC Public Health. 2017 May 2;17(1):378
pubmed: 28464934
Dtsch Arztebl Int. 2020 Jan 6;117(1-2):7-13
pubmed: 32008606
Nicotine Tob Res. 2014 Dec;16(12):1537-8
pubmed: 25320111
Dtsch Arztebl Int. 2020 Mar 13;117(11):177-182
pubmed: 32327029
Psychopharmacology (Berl). 2014 Jan;231(1):37-42
pubmed: 23873417
Addiction. 2014 Mar;109(3):491-9
pubmed: 24372901
Addiction. 2011 Mar;106(3):631-8
pubmed: 21134020
Cochrane Database Syst Rev. 2021 Sep 14;9:CD010216
pubmed: 34519354
Nicotine Tob Res. 2019 Jan 1;21(1):119-126
pubmed: 29660034
N Engl J Med. 2019 Feb 14;380(7):629-637
pubmed: 30699054
Addiction. 2014 Sep;109(9):1531-40
pubmed: 24846453
Pneumologie. 2014 Apr;68(4):237-58
pubmed: 24570269